Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study

Fragile X-associated primary ovarian insufficiency (FXPOI) is due to an X-linked mutation that results from the expansion of a CGG repeat sequence located in the 5' untranslated region of the FMR1 gene (premutation, PM). About 20% of women who carry the PM have cessation of menses before age 40...

Full description

Bibliographic Details
Main Authors: Emily G. Allen, Wendy E. Grus, Sarayu eNarayan, Whitney eEspinel, Stephanie L. Sherman
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-08-01
Series:Frontiers in Genetics
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fgene.2014.00260/full
_version_ 1818364304672423936
author Emily G. Allen
Wendy E. Grus
Sarayu eNarayan
Whitney eEspinel
Stephanie L. Sherman
author_facet Emily G. Allen
Wendy E. Grus
Sarayu eNarayan
Whitney eEspinel
Stephanie L. Sherman
author_sort Emily G. Allen
collection DOAJ
description Fragile X-associated primary ovarian insufficiency (FXPOI) is due to an X-linked mutation that results from the expansion of a CGG repeat sequence located in the 5' untranslated region of the FMR1 gene (premutation, PM). About 20% of women who carry the PM have cessation of menses before age 40, a clinical condition known as premature ovarian failure (POF). This leads to a 20-fold increased risk over women in the general population. Thus, this single gene mutation has a major effect on reducing a woman’s reproductive life span. Based on survival analysis of about 1300 women, we showed that the mean age at menopause among PM carriers is reduced compared with noncarriers, even after removing women who reported POF. This suggests that the majority of women with the PM, not just a subset, experience ovarian insufficiency earlier than noncarriers. To better understand the underlying mechanism of the PM and to identify genes that modify the variable expressivity of FXPOI, we conducted two pilot studies. The first focused on five common variants known to reduce age at menopause. We genotyped these SNPs in 72 women with a PM who experienced menopause and found a significant association with the total SNP risk burden and age at menopause. This suggests that these SNPs influence onset of FXPOI, after adjusting for the effect of the PM allele. In the second approach, we conducted whole genome sequencing on ten PM carriers, five with onset of FXPOI prior to age 30 and five who experienced menopause after age 47 years. Although only a pilot study, we describe our preliminary approach to identify potential variants that may play a role in modifying onset of FXPOI and potentially play a role in idiopathic primary ovarian insufficiency. The overarching goal of both approaches is to identify predictor variants that may identify women predisposed to early onset FXPOI and to further identify genes involved in defining a woman’s reproductive life span.
first_indexed 2024-12-13T22:02:15Z
format Article
id doaj.art-d1ca908cd9e4434da80385a34acda333
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-12-13T22:02:15Z
publishDate 2014-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-d1ca908cd9e4434da80385a34acda3332022-12-21T23:29:58ZengFrontiers Media S.A.Frontiers in Genetics1664-80212014-08-01510.3389/fgene.2014.00260100650Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary studyEmily G. Allen0Wendy E. Grus1Sarayu eNarayan2Whitney eEspinel3Stephanie L. Sherman4Emory UniversityKnome Inc.Emory UniversityEmory UniversityEmory UniversityFragile X-associated primary ovarian insufficiency (FXPOI) is due to an X-linked mutation that results from the expansion of a CGG repeat sequence located in the 5' untranslated region of the FMR1 gene (premutation, PM). About 20% of women who carry the PM have cessation of menses before age 40, a clinical condition known as premature ovarian failure (POF). This leads to a 20-fold increased risk over women in the general population. Thus, this single gene mutation has a major effect on reducing a woman’s reproductive life span. Based on survival analysis of about 1300 women, we showed that the mean age at menopause among PM carriers is reduced compared with noncarriers, even after removing women who reported POF. This suggests that the majority of women with the PM, not just a subset, experience ovarian insufficiency earlier than noncarriers. To better understand the underlying mechanism of the PM and to identify genes that modify the variable expressivity of FXPOI, we conducted two pilot studies. The first focused on five common variants known to reduce age at menopause. We genotyped these SNPs in 72 women with a PM who experienced menopause and found a significant association with the total SNP risk burden and age at menopause. This suggests that these SNPs influence onset of FXPOI, after adjusting for the effect of the PM allele. In the second approach, we conducted whole genome sequencing on ten PM carriers, five with onset of FXPOI prior to age 30 and five who experienced menopause after age 47 years. Although only a pilot study, we describe our preliminary approach to identify potential variants that may play a role in modifying onset of FXPOI and potentially play a role in idiopathic primary ovarian insufficiency. The overarching goal of both approaches is to identify predictor variants that may identify women predisposed to early onset FXPOI and to further identify genes involved in defining a woman’s reproductive life span.http://journal.frontiersin.org/Journal/10.3389/fgene.2014.00260/fullMenopausePrimary Ovarian InsufficiencyEpistasisdisorderRepeat expansionovarian failure
spellingShingle Emily G. Allen
Wendy E. Grus
Sarayu eNarayan
Whitney eEspinel
Stephanie L. Sherman
Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study
Frontiers in Genetics
Menopause
Primary Ovarian Insufficiency
Epistasis
disorder
Repeat expansion
ovarian failure
title Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study
title_full Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study
title_fullStr Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study
title_full_unstemmed Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study
title_short Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study
title_sort approaches to identify genetic variants that influence the risk for onset of fragile x associated primary ovarian insufficiency fxpoi a preliminary study
topic Menopause
Primary Ovarian Insufficiency
Epistasis
disorder
Repeat expansion
ovarian failure
url http://journal.frontiersin.org/Journal/10.3389/fgene.2014.00260/full
work_keys_str_mv AT emilygallen approachestoidentifygeneticvariantsthatinfluencetheriskforonsetoffragilexassociatedprimaryovarianinsufficiencyfxpoiapreliminarystudy
AT wendyegrus approachestoidentifygeneticvariantsthatinfluencetheriskforonsetoffragilexassociatedprimaryovarianinsufficiencyfxpoiapreliminarystudy
AT sarayuenarayan approachestoidentifygeneticvariantsthatinfluencetheriskforonsetoffragilexassociatedprimaryovarianinsufficiencyfxpoiapreliminarystudy
AT whitneyeespinel approachestoidentifygeneticvariantsthatinfluencetheriskforonsetoffragilexassociatedprimaryovarianinsufficiencyfxpoiapreliminarystudy
AT stephanielsherman approachestoidentifygeneticvariantsthatinfluencetheriskforonsetoffragilexassociatedprimaryovarianinsufficiencyfxpoiapreliminarystudy